PUBLISHER: The Business Research Company | PRODUCT CODE: 1657067
PUBLISHER: The Business Research Company | PRODUCT CODE: 1657067
A veterinary stereotactic radiosurgery system is a form of external radiation therapy that precisely positions the patient while delivering a single, high dosage of radiation to a tumor.
The primary types of veterinary stereotactic radiosurgery systems encompass microsurgical instrumentation, optical or viewing instruments, and other related products. Microsurgical instrumentation refers to hand-held surgical tools designed specifically for microsurgical and delicate procedures, facilitating the handling of fragile tissues, tendons, and blood vessels. Various modalities involved in these systems include gamma knife, linear accelerator, particle beam radiation therapy, and cyber knife, which are utilized for applications in canine, feline, and other veterinary scenarios. Different end users for these systems include hospitals, contract research organizations (CROs), and other relevant entities.
The veterinary stereotactic radiosurgery system market research report is one of a series of new reports from The Business Research Company that provides veterinary stereotactic radiosurgery system market statistics, including veterinary stereotactic radiosurgery system industry global market size, regional shares, competitors with veterinary stereotactic radiosurgery system market share, detailed veterinary stereotactic radiosurgery system market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary stereotactic radiosurgery system industry. This veterinary stereotactic radiosurgery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The veterinary stereotactic radiosurgery system market size has grown rapidly in recent years. It will grow from $2.92 billion in 2024 to $3.28 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increasing pet ownership, veterinary healthcare investments, regulatory support, growing pet insurance.
The veterinary stereotactic radiosurgery system market size is expected to see rapid growth in the next few years. It will grow to $5.28 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to expanding geriatric pet population, rising awareness and education, globalization of veterinary services. Major trends in the forecast period include integration of ai and robotics, continuous technological innovation, increased focus on personalized medicine, telemedicine integration, collaborations and partnerships, growing popularity of cyberknife and linac systems, focus on minimally invasive procedures.
The growth of the veterinary stereotactic radiosurgery system market is anticipated to be driven by the increasing pet population. Pets, referring to animals kept in homes for enjoyment and companionship, can benefit from the veterinary stereotactic radiosurgery system, which aids in treating tumors in pets with diverse head sizes and shapes. According to the People's Dispensary Sick Animals wellness (PAW) Report, the UK's largest annual examination of pet wellness, 53% of UK adults are projected to own a pet in 2023, showcasing an increase from 51% in February 2020. Among them, 29% own a dog, 24% own a cat, and 2% own a rabbit. The veterinary practitioners report a 67% increase in the pet population over the last two years, with 71% attributing it to more pets in their clinics and 54% to an increase in new pets in their communities. Therefore, the surge in the pet population is a significant driver of the veterinary stereotactic radiosurgery system market.
An increase in pet health awareness is anticipated to drive the growth of the veterinary stereotactic radiosurgery system market in the future. Pet health awareness refers to the understanding and knowledge that pet owners have regarding their pets' health requirements and the importance of preventive care. As pet owners become more conscious of their pets' health needs and the benefits of preventive treatments, they are increasingly choosing advanced treatment options such as stereotactic radiosurgery. For example, in 2022, the U.S. Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) announced that it would allocate over $16.3 million to 64 projects in collaboration with states, universities, and other partners to enhance programs aimed at safeguarding animal health. Consequently, the rise in pet health awareness is propelling the growth of the veterinary stereotactic radiosurgery system market.
Technological advancements represent a prominent trend in the veterinary stereotactic radiosurgery system market. Key players are actively developing advanced technologies to maintain their position in the market. For example, Accuray Incorporated, a U. S. -based manufacturer of radiotherapy systems, introduced the CyberKnife S7 system, the latest iteration of its CyberKnife radiation therapy platform. Leveraging robotic radiation therapy, the S7 system administers stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments within a 15-minute timeframe. It addresses neurological diseases, benign, and malignant cancers across the body. The system utilizes Accuray's Synchrony motion-synchronization technology to tailor radiation administration in real-time based on patient and/or tumor movement. The unique robotic architecture allows radiation delivery from numerous angles.
In October 2022, Aspen Surgical Products Inc., a U. S. -based full-service veterinary hospital, acquired Symmetry Surgical, enhancing its portfolio and commercial capabilities. Symmetry Surgical, a U. S. -based provider of surgical instrumentation and solutions, adds clinically favored products to Aspen's portfolio, enabling diversification into more desirable adjacent categories.
In June 2022, Telix Pharmaceuticals Limited, an Australian biotechnology firm, partnered with RefleXion Medical Inc. The collaboration aims to develop 68Ga PSMA-PET imaging agents for use with BgRT, potentially extending this exclusive partnership beyond the U.S. to aid in the regulatory approval of Illuccix and improve the detection and treatment of metastatic disease. RefleXion Medical Inc. is a U.S.-based medical device company that specializes in innovative cancer therapies and offers a veterinary stereotactic radiosurgery system.
Major companies operating in the veterinary stereotactic radiosurgery system market include PetCure Oncology, Elekta AB, Accuray Incorporated, Varian Medical Systems Inc., Nanovi Radiotherapy A/S, Ion Beam Applications SA, ZAP Surgical Systems Inc., Brainlab AG, Best Medical International Inc., Mevion Medical Systems Inc., Hitachi Ltd., Sumitomo Heavy Industries Ltd., Shinva Medical Instrument Co. Ltd., Beijing Wandong Medical Equipment Co. Ltd., Neusoft Medical Systems Co. Ltd., Xinjiang Xinxing Medical Equipment Co. Ltd., Beijing Neusoft Medical Systems Co. Ltd., Siemens Healthineers AG, Philips Healthcare Company, GE Healthcare Technologies Inc., Toshiba Medical Systems Corporation, Hitachi Aloka Medical Ltd., Vision RT Limited
North America was the largest region in the veterinary stereotactic radiosurgery system market in 2024. The regions covered in the veterinary stereotactic radiosurgery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the veterinary stereotactic radiosurgery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
A veterinary stereotactic radiosurgery system market includes revenues earned by entities by veterinary stereotactic radiosurgery system that are used in the treatment of cancers and other issues that affect the brain, neck, lungs, liver, spine, and other areas of the body of pets and animals. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Stereotactic Radiosurgery System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on veterinary stereotactic radiosurgery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for veterinary stereotactic radiosurgery system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary stereotactic radiosurgery system market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.